New drug trial aims to protect hearts during attack treatment
NCT ID NCT07362446
Summary
This study tests whether a single dose of Xolatryp given during emergency heart attack treatment can improve recovery. 300 adults having a severe heart attack will receive either Xolatryp or a placebo infusion during their procedure. Researchers will monitor heart health for 30 days to see if Xolatryp reduces heart damage and improves outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nepean Hospital
Kingswood, New South Wales, 2747, Australia
-
Northern Health
Epping, Victoria, 3076, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Sir Charles Gairdner Hospital
Nedlands, Western Australia, 6009, Australia
-
Sunshine Hospital
Saint Albans, Victoria, 3021, Australia
Conditions
Explore the condition pages connected to this study.